Celular therapy in patients with pseudoarthrosis: analysis of costs and consequences
PDF
PDF (Español (España))
PDF (Português (Brasil))
HTML
HTML (Español (España))
HTML (Português (Brasil))

Supplementary Files

Cell therapy in patients with pseudarthrosis: cost analysis and consequences (Português (Brasil))

Keywords

Costs
Stem Cell
Consequences
Pseudoarthrosis
Nursing
Economical Analysis. Costo
Células Tronco
Consecuencias
Pseudartrosis
Enfermería
Evaluación económica. Custo
Células-tronco
Consequência
pseudartrose
Enfermagem
Avaliação Econômica.

Abstract

The treatment of pseudoarthrosis is often long and with great financial and social cost. The aim of this study was to analyze the costs and consequences of stem cells application in patients with pseudoarthrosis. Methodology: This study is an economic analysis of costs and consequences. It was undertaken in a University Hospital from September 2008 to December 2010. The direct costs and time to fracture healing of eight patients were raised. Results: The follow up of patients after the procedure was for six months. From eight patients, seven were healed. The healing time was an average of 14.7 weeks. The direct costs of hospital treatment was R$ 1,207.75. Conclusion: The results of this study are encouraging. The future challenge will be to increase the sample and evaluate the effectiveness of this procedure.

Descriptors: Cost; Consequence Analysis;  Economics, Nursing.

Received: 09/20/2011

Approved: 04/19/2012

https://doi.org/10.5935/1676-4285.20120017
PDF
PDF (Español (España))
PDF (Português (Brasil))
HTML
HTML (Español (España))
HTML (Português (Brasil))

References

Silveira CD, Vieira S, Souza FSL, Oliveira FT, Mattos VZ, Marins ALC, Moura SM. Stemcell therapy for cardiology: a new path to humanity and a new care for nurses - a case report. Online Braz J Nurs (OBJN-ISSN 1676-4285) [online] 2005 Apr [Acesso em 2010 oct 8]; 4(1) Available in:www.uff.br/nepae/objn401silveiraetal.htm.

Reis FB, Neto JSH, Pires RES. Pseudartrose. Rev. Bras. Ortop. 2005 Mar; 40 (3): 79-88.

Beredjiklian PK, Naranja RJ, Heppenstall RB, Brighton CT, Esterhai JL. Results of Treatment of 111 Patients With Nonunion of Femoral Shaft Fractures. UPOJ 1999; 12: 52–56.

Zabeu JLA, Mercadante MT. Substitutos ósseos comparados ao enxerto ósseo autólogo em cirurgia ortopédica: revisão sistemática da literatura. Rev. bras. ortop. [online]. 2008 [acessado 2011 Fev 17]; 43(3): 59-68. Disponível em: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S010236162008000200002&lng=en.http://dx.doi.org/10.1590/S0102-36162008000200002.

Arone EM, Cunha ICKO. Avaliação tecnológica como competência do enfermeiro: reflexões e pressupostos no cenário da ciência e tecnologia. Rev. bras. enferm. Brasília 2006 Aug; 59(4): 569-572.

Costa AMN, Secoli SR, Nita ME. Avaliação econômica: análise de custo-minimização, análise de custo-consequência, estudo de custo da doença e outras análise parciais in Avaliação de Tecnologias em Saúde: evidências clínicas, análise econômica e análise de decisão. Porto Alegre: Artmed 2010; 354- 367.

Niedźwiedzki T. Effect of bone marrow on healing of fractures, delayed unions and pseudoarthroses of long bones. Chir Narzadow Ruchu Ortop Pol. 1993; 58(3):194-204.

Hernigou P, Poignard A, Beaujean F, Rouard H. Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. J. Bone Joint Surg. Am. 2005 Jul; 87(7): 1430-7.

Bhandari M, Tornetta P, Sprague S, Najibi S, Petrisor B, Griffith L, et al. Predictors of reoperation following operative management of fractures of the tibial shaft. J Orthop Trauma 2003; 17: 353-61.

Healey JH, Zimmermaan PA, McDonnellm JM, Lanem JM. Percutaneous Bone Marrow Grafting of Delayed Union and Nonunion in Cancer Patients. Bone Marrow Grafting 1990 Jul; (256):280-5.